Valent BioSciences Files Patent Applications Claiming Benefits of Abscisic Acid in Animal Feed

FOR IMMEDIATE RELEASE

Studies show potential use for better health, growth, and feed conversion efficiencies.

LIBERTYVILLE, IL., February 16, 2012 – Valent BioSciences Corporation announced today it has filed worldwide patent applications claiming beneficial effects of an animal feed diet supplemented with abscisic acid (S-ABA). S-ABA is a naturally occurring substance found in all plants, including crops such as corn, wheat, and soybeans, as well as fruits and vegetables.

The patent applications cite new research that indicates a range of potential benefits resulting from the addition of S-ABA into poultry feed, including better overall health, improved weight gain, and enhanced feed conversion ratios.

“As the only global manufacturer and marketer of S-ABA, we’re excited to be further exploring potential commercial opportunities for both crop and non-crop uses with this molecule” said Warren E. Shafer, Valent BioSciences’ Vice President of Global Research & Development and Regulatory Affairs.

The filings are part of a series of global patents and patent applications sought by the Illinois-based biotechnology company, which has commercialized two products based on S-ABA for crop use in the last three years. ProTone® Plant Growth Regulator was launched in 2009 to enhance color in table grapes, while BioNikTM Plant Growth Regulator is being launched in 2012 as a seed treatment to extend the window of pollen shed in hybrid corn seed production.

###

About Valent BioSciences Corporation
Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company. Valent BioSciences is the worldwide leader in the development, manufacturing and commercialization of biorational products, with sales in over 90 countries around the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

Media Contact:
Barbara Wendling
Valent BioSciences Corporation
847-968-4793
Email: barbara.wendling@valentbiosciences.com

Download Press Release

Share:

Related News

WHITE CITY, Ore., September 21, 2023 – To meet the increasing demands and...
Broadening its commitment to sustainability and corporate social value, Valent BioSciences LLC formally dedicated a new prairie park and solar field adjacent to its manufacturing facility in Osage, Iowa, on June 24.
The Pest Management Regulatory Agency (PMRA) recently approved, for the first time, drone use as an application method for three Public Health products from Valent BioSciences LLC.
Valent BioSciences LLC, a global leader in the discovery, development, and commercialization of highly effective, low-risk, environmentally compatible technologies and products for agriculture, public health, and forest health, announces the retirement of President and CEO Ted Melnik, effective July 2023. In addition, Salman Mir, currently Executive Vice President and Chief Operating Officer, has been named President and CEO, also effective July 2023.
Valent BioSciences LLC announces its acquisition of FBSciences Holdings, Inc., a leader in the discovery and commercialization of naturally derived plant, soil, and climate health solutions.
The new solar field at Valent BioSciences’ manufacturing facility in Osage, Iowa, is now fully operational.